SCHEMBL6973694

SCHEMBL6973694

CN1CCN(C(=O)C2CCCN2C(=O)OC(C)(C)C)CC1

nearest known ligand 0.71

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.71
HRH2 P25021 1/20 0.54
HRH1 P35367 1/20 0.54
UCHL1 P09936 3/20 0.52
SMN1; SMN2 Q16637 1/20 0.47
NPC1 O15118 1/20 0.47
HPGD P15428 1/20 0.47
LMNA P02545 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
USP30 Q70CQ3 1/20 0.45
WNT3 P56703 2/20 0.44
SFRP1 Q8N474 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3274885 1.00 HSD17B10 (0.71) HSD17B10HRH2HRH1UCHL1SMN1; SMN2
SCHEMBL13779912 1.00 HSD17B10 (0.71) HSD17B10HRH2HRH1UCHL1SMN1; SMN2
SCHEMBL13779915 0.96 HSD17B10 (0.66) HSD17B10HRH2HRH1UCHL1SMN1; SMN2
SCHEMBL5219163 0.90 HSD17B10 (0.77) HSD17B10HRH2HRH1UCHL1HPGD
SCHEMBL3280014 0.90 HSD17B10 (0.77) HSD17B10HRH2HRH1UCHL1HPGD
SCHEMBL18461898 0.90 HSD17B10 (0.77) HSD17B10HRH2HRH1UCHL1HPGD
SCHEMBL30065870 0.89 HSD17B10 (0.76) HSD17B10HRH2HRH1UCHL1SMN1; SMN2
SCHEMBL3274878 0.88 HSD17B10 (0.75) HSD17B10HRH2HRH1UCHL1HPGD
SCHEMBL6979623 0.88 HSD17B10 (0.75) HSD17B10HRH2HRH1UCHL1HPGD
SCHEMBL5429775 0.87 HSD17B10 (0.72) HSD17B10HRH2HRH1UCHL1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001094341-A9 QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF TUMOURS ASTRAZENECA AB (SE) 2003-04-17 WO disclosed
EP-1292594-A1 QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF TUMOURS AstraZeneca AB (SE) 2003-03-19 EP disclosed
WO-2001094341-A1 QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF TUMOURS ASTRAZENECA AB (SE) 2001-12-13 WO disclosed